CLOV — Clover Health Investments, Corp.

Clover Health Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Membership Growth: Clover Health's Medicare Advantage membership increased by 35% year-over-year, reaching over 109,000 members.
• Insurance Revenue: Revenue grew by nearly 50% year-over-year to $479 million for Q3, with year-to-date insurance revenue at $1.4 billion, up 39%.
• Adjusted EBITDA: Clover maintained adjusted EBITDA profitability year-to-date, reporting $2 million for Q3, down from $19 million year-over-year. Year-to-date adjusted EBITDA is $45 million.
• Adjusted Net Income: Also reported at $2 million for Q3, with year-to-date adjusted net income at $44 million.
• Medical Cost Trends: Underlying incurred medical costs increased by 4% year-over-year, excluding pharmacy.

2. Strategic Updates and Business Highlights

• Clover Assistant: The technology continues to drive clinical quality, achieving a HEDIS score of 4.72, making Clover the top-performing PPO in the country for clinical quality.
• Star Ratings: Clover received a 3.5-star rating for 2026, which is below their aspiration of 4 stars. The company is focused on improving pharmacy measures that impacted their star ratings.
• Counterpart Health: Progress in expanding technology capabilities, including integrated scribing and generative AI tools to enhance physician efficiency and patient care.
• Enrollment Strategy: Clover is targeting priority markets with existing member bases and strong Clover Assistant coverage to drive growth.

3. Forward Guidance and Outlook

• Membership Guidance: Revised to average between 106,000 and 108,000 members for 2025, reflecting 33% growth year-over-year.
• Insurance Revenue Guidance: Increased to between $1.850 billion and $1.880 billion for 2025.
• Adjusted EBITDA and Net Income Guidance: Lowered to between $15 million and $30 million due to pressures from new member growth and utilization trends.
• 2026 Expectations: Anticipation of a return to profitability with a larger base of returning members, improved star ratings, and enhanced Clover Assistant capabilities.

4. Bad News, Challenges, or Points of Concern

• Utilization Pressure: Increased medical expenses and utilization rates, particularly among new members, are impacting profitability.
• Star Ratings: The low star rating of 3.5 is seen as a setback, particularly affecting member attraction despite high clinical quality scores.
• New Member Dynamics: The influx of new members is diluting profitability as they are generally loss-making in their first year.
• Market Competition: Industry-wide pressures from competitors reducing benefits and exiting markets have created challenges in managing costs and member performance.

5. Notable Q&A Insights

• BER Perspective: Analysts questioned the expected increase in the benefit expense ratio (BER) for 2026, with management indicating that current trends are factored into their bids and they are focused on targeted growth in priority markets.
• Cost Management: Management expressed confidence in their ability to manage costs effectively despite current pressures, citing strong retention rates and the anticipated maturation of new member cohorts.
• Future Projections: There was discussion on the expected improvement in core metrics as new members transition into returning cohorts, which typically show better financial performance.

Overall, Clover Health remains optimistic about its long-term trajectory despite facing short-term challenges related to growth dynamics and utilization pressures. The company is focused on leveraging its technology and improving member outcomes to drive future profitability.